InsiderTrades

Form 4 for LMAT LEMAITRE VASCULAR INC

Accepted 2023-12-21 00:00:00 ET · period of report 2023-12-19 · accession 0001437749-23-035159 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-12-21 2023-12-19+ LMAT LeMaitre George W COB, CEO, Dir, 10% M - OptEx $0.00 +129 2.27M +0.0% $0
DM 2023-12-21 2023-12-19+ LMAT LeMaitre George W COB, CEO, Dir, 10% F - Tax $55.58 -1,204 2.27M -0.1% -$66.9K
DM 2023-12-21 2023-12-19+ LMAT LeMaitre George W COB, CEO, Dir, 10% M - OptEx $0.00 -129 2.67 -98% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-12-19 M A 85 $0.00 2,268,310 D — — (F1) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
2 Common Common Stock 2023-12-19 F D 728 $56.06 2,267,582 D — — (F3) These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/19/2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
3 Common Common Stock 2023-12-19 M A 2 $0.00 2,267,584 D — — (F2) Represents shares acquired from the release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
4 Common Common Stock 2023-12-20 M A 42 $0.00 2,267,626 D — — (F1) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
5 Common Common Stock 2023-12-20 F D 476 $54.85 2,267,150 D — — (F4) These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/20/2019. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
6 Derivative Dividend Equivalent Rights 2023-12-19 M D 2 $0.00 0 D — · — to — 2 Common Stock (F5) These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/19/2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
7 Derivative Dividend Equivalent Rights 2023-12-20 M D 42 $0.00 46.59 D — · — to — 42 Common Stock (F6) These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/20/2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
8 Derivative Dividend Equivalent Rights 2023-12-19 M D 85 $0.00 2.67 D — · — to — 85 Common Stock (F5) These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/19/2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.